Pilot Social Network Weight Loss Intervention (HIC)
Healthy Immigrant Community: Pilot Social Network Weight Loss Intervention
Specific Aim #1: Pilot test a social network-informed CBPR-derived health promotion program for feasibility outcomes with overweight or obese adults from two immigrant communities.
Specific Aim #2: Assess the preliminary impact of embedding a social network-informed CBPR-derived intervention within a regional health promotion resource hub on sustainability and uptake outcomes.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The intervention will consist of 12 community-based mentoring and education sessions, group activities and application of a community toolkit for healthy weight loss delivered by trained interventionists from Hispanic and Somali communities to their social networks. Using a pre-post study design, 4 social networks of adults with approximately 32 network participants will receive the intervention. Primary outcomes, measured 3 months after implementation, will include feasibility measures of acceptability, implementation, and practicality. Secondary outcomes will include BMI, waist circumference, blood pressure, fasting blood glucose, total cholesterol, physical activity level, dietary change, and health-related quality of life.
Eligibility criteria include (1) self-identification as Hispanic or Somali, (2) member of an HPs social network, (3) age≥18 and <65 (4) willingness to participate in all aspects of the study; and (5) provision of informed consent. Exclusion criteria include (1) pregnancy at the time of enrollment and (2) serious medical conditions or disabilities that would make physical activity difficult.
We will test how best to integrate a social network intervention within an existing evidence-based regional health promotion infrastructure (WellConnect) that will enhance its potential dissemination and community-wide uptake
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Minnesota
-
Rochester, Minnesota, Forente stater, 55905
- Mayo Clinic
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- self-identification as Hispanic or Somali
- member of an HPs social network
- age≥18 and <65
- willingness to participate in all aspects of the study
- provision of informed consent.
Exclusion Criteria:
- pregnancy at the time of enrollment
serious medical conditions or disabilities that would make physical activity difficult.
- To avoid stigmatization, a normal weight (BMI<25) will not exclude individuals from participating, but they will be excluded from the measurements and analyses.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention
All participants will receive education on maintaining a healthy diet and improving physical activity.
|
12 mentoring/educational sessions focused on physical activity and healthy nutrition by Mayo Clinic experts.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Acceptability
Tidsramme: 12 weeks
|
To what extent did was the intervention judged as relevant, satisfying, or helpful to HPs and participants?
Interviews with HPs; focus groups and survey with participants.
|
12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Weight
Tidsramme: 12 weeks
|
Weight will be measured to the nearest 0.1 kg using a portable scale (Seca 880 Digital Floor Scale).
BMI is calculated as weight (kg)/height squared (m2).
|
12 weeks
|
|
Waist circumference
Tidsramme: 12 weeks
|
Waist circumference will be measured to the nearest 0.1 cm at the narrowest part of the torso between the ribs and the iliac crest.
Participants will remove all excess clothing prior to the measurement and smooth the remaining clothing against the skin.
Two measurements will be taken; if the difference between the two measures is more than 2.0 cm, a third measurement will be taken.
The average of the two closest measures will be used for analyses.
|
12 weeks
|
|
Glucose
Tidsramme: 12 weeks
|
Collected by a single finger prick.
Participants will be asked to refrain from eating for at least 6 hours prior to testing.
Samples used for testing are whole blood from a fingerstick collected in a lithium heparin coated capillary tube.
|
12 weeks
|
|
Cholesterol
Tidsramme: 12 weeks
|
Collected by a single finger prick.
Participants will be asked to refrain from eating for at least 6 hours prior to testing.
The portable Whole Blood Lipid Screen Cholestech LDX Analyzer will be used to analyze specimens, which combines enzymatic methodology and solid-phase technology measured by reflectance photometry to measure total cholesterol, HDL cholesterol, triglycerides and glucose in whole blood.
LDL cholesterol is a calculated value.
Samples used for testing are whole blood from a fingerstick collected in a lithium heparin coated capillary tube.
Results will be recorded at the site of collection and samples will be destroyed upon recording of results.
|
12 weeks
|
|
Height
Tidsramme: 12 weeks
|
Height will be measured to the nearest 0.1 cm at baseline only using a stadiometer.
|
12 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Mark Wieland, MD, Mayo Clinic
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 19-011574
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Mentoring/educational session
-
Columbia UniversityFullført
-
University of California, San FranciscoGeorge Washington University; American Cancer Society, Inc.; London School...Fullført
-
Gazi UniversityFullført
-
University of UlsterQueen's University, Belfast; University of Bristol; Marie Curie Hospice,...Fullført
-
University of Sao PauloFullført
-
University of WashingtonAktiv, ikke rekrutterendeAldring | Utilsiktet fallForente stater
-
Ziauddin UniversityUniversiti Sains MalaysiaHar ikke rekruttert ennåGingivitt | Plakk på tennenePakistan
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)FullførtBarnekreftoverlevendeForente stater
-
Jury CandelarioMerck Sharp & Dohme LLCUkjent
-
Wake Forest University Health SciencesPatient-Centered Outcomes Research Institute; Atrium Health Levine Cancer...FullførtSigdcellesykdomForente stater